The Drug Discovery Innovation Programme (DDIP) Europe brings together senior leaders from pharma, biotech, academia, and technology providers to explore the latest advances transforming drug discovery. Through thought-provoking discussions, real-world case studies, and strategic networking, DDIP provides a platform for collaboration across AI, translational science, biologics, computational approaches, and emerging therapeutic modalities.
Join the community of innovators accelerating the journey from breakthrough science to life-changing medicine.
Join a focused, two days B2B conference, designed to spark meaningful dialogue, strategic partnerships, and explore practical solutions shaping the future of drug discovery.
With 100+ carefully selected attendees, the event maintains an intimate setting that enables real conversations, not crowded halls.
Our audience is 80% pharma & biotech leaders, 20% solution providers, ensuring balanced, quality discussions driven by real industry needs.
No oversized expos or generic sessions. Just two days of curated content, expert speakers, and actionable takeaways that deliver real ROI.
